It is a healthcare private limited company based in New Delhi, Delhi, India, established in 2009.
2009 | New Delhi, Delhi, India | ActiveTirupati Pharmaceuticals Private Limited, a active private limited company, was established on 16 July 2009 in New Delhi, Delhi, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U52100DL2009PTC192276. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.60 M and a paid-up capital of ₹0.60 M.
It upholds a compliant status. Its leadership includes Hemant Sachdeva (Director), Anubhav Malik (Director), Jyoti Malik (Director). Past directors included Virain Khatri, Satish Kumar, Rajeev Malik. It holds ₹1.00 M open charges and no settled loans. Its latest AGM occurred on 29 September 2021, with the balance sheet filed on 31 March 2021. It is based at G-1, Plot No. 11, Tirupati Plaza, Pocket 4 Sector-11, Dwarka, New Delhi, Delhi, 110075.
U52100DL2009PTC192276
192276
16 July 2009
₹0.60 M
₹0.60 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Tirupati Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hemant Sachdeva | Director | 01 Jan 2021 | Current |
| Anubhav Malik | Director | 01 Jan 2021 | Current |
| Jyoti Malik | Director | 01 Jun 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Jul 2012 | Past |
| Pramod Abcsdd | Director | 01 Jun 2017 | Past |
| Pramod Abcsdd | Director | 01 Jan 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Tirupati Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 30.22% decrease. The company also saw a substantial fall in profitability, with a 13.49% decrease in profit. The company's net worth Soared by an impressive increase of 15.16%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Tirupati Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Feb 2016 | Others | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Tirupati Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Tirupati Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tirupati Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Tirupati Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2021 as per latest MCA records. was completed.
Progress on Tirupati Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Delhi. was documented.
Hemant Sachdeva was appointed as a Director was appointed as a Director on 01 Jan 2021 & has been associated with this company since 4 years 11 months . was recorded as a recent event.
Progress on Anubhav Malik was appointed as a Director was appointed as a Director on 01 Jan 2021 & has been associated with this company since 4 years 11 months . was documented.
The activity A charge with Others of Rs. 1.00 M registered on 01 Feb 2016 with Charge ID 10627891 was modified on 20 Feb 2018. was completed.
Progress on Jyoti Malik was appointed as a Director was appointed as a Director on 01 Jun 2017 & has been associated with this company since 8 years 6 months . was documented.
The CIN of Tirupati Pharmaceuticals Private Limited is U52100DL2009PTC192276.
Tirupati Pharmaceuticals Private Limited is headquartered at G-1, Plot No. 11, Tirupati Plaza, Pocket 4 Sector-11, Dwarka, New Delhi, Delhi, 110075.
Tirupati Pharmaceuticals Private Limited was incorporated on 16 July 2009.
The current directors of Tirupati Pharmaceuticals Private Limited are
The primary industry of Tirupati Pharmaceuticals Private Limited is Trade.
Tirupati Pharmaceuticals Private Limited is unlisted.
The authorized capital of Tirupati Pharmaceuticals Private Limited is ₹0.60 M, and the paid-up capital is ₹0.60 M.
The compliance status of Tirupati Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX